Leber hereditary optic neuropathy

被引:353
|
作者
Man, PYW [1 ]
Turnbull, DM [1 ]
Chinnery, PF [1 ]
机构
[1] Newcastle Univ, Sch Med, Sch Neurosci & Psychiat, Dept Neurol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
D O I
10.1136/jmg.39.3.162
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Leber hereditary optic neuropathy (LHON) is a mitochondrial genetic disease that preferentially causes blindness in young adult males, affecting about 1 in 25 000 of the British population. It is characterised by bilateral subacute loss of central vision owing to focal degeneration of the retinal ganglion cell layer and optic nerve. Over 95% of LHON cases are primarily the result of one of three mitochondrial DNA (mtDNA) point mutations, G3460A, G1 1778A, and T14484C, which all involve genes encoding complex I subunits of the respiratory chain. An intriguing feature of LHON is that only similar to50% of males and similar to10% of females who harbour a pathogenic mtDNA mutation actually develop the optic neuropathy. This marked incomplete penetrance and gender bias imply that additional mitochondrial and/or nuclear genetic factors must be modulating the phenotypic expression of LHON. It is also likely that environmental factors contribute to the onset of visual failure. However, these secondary precipitating factors remain poorly defined at present. In this review, we describe the natural history of this optic nerve disorder and highlight issues relating to clinical diagnosis, management, and genetic counselling. We also discuss the findings of recently published studies and the light they shed on the complex aetiology and pathophysiology of LHON.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 50 条
  • [21] NUCLEAR COMPLEMENTATION IN LEBER HEREDITARY OPTIC NEUROPATHY
    COCK, HR
    COOPER, JM
    SCHAPIRA, AHV
    [J]. NEUROLOGY, 1995, 45 (04) : A294 - A294
  • [22] Developments in the Treatment of Leber Hereditary Optic Neuropathy
    Benson S. Chen
    Patrick Yu-Wai-Man
    Nancy J. Newman
    [J]. Current Neurology and Neuroscience Reports, 2022, 22 : 881 - 892
  • [23] Leber hereditary optic neuropathy in the population of Serbia
    Jancic, Jasna
    Dejanovic, Ivana
    Samardzic, Janko
    Radovanovic, Sasa
    Pepic, Ana
    Kosanovic-Jakovic, Natalija
    Cetkovic, Mila
    Kostic, Vladimir
    [J]. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2014, 18 (03) : 354 - 359
  • [24] IDEBENONE FOR LEBER'S HEREDITARY OPTIC NEUROPATHY
    Gueven, N.
    [J]. DRUGS OF TODAY, 2016, 52 (03) : 173 - 181
  • [25] Clinical Overview of Leber Hereditary Optic Neuropathy
    Stramkauskaite, Almina
    Povilaityte, Ieva
    Glebauskiene, Brigita
    Liutkeviciene, Rasa
    [J]. ACTA MEDICA LITUANICA, 2022, 29 (01) : 9 - 18
  • [26] Updated Review of Leber Hereditary Optic Neuropathy
    Michael G. Carper
    Amanda D. Henderson
    [J]. Current Treatment Options in Neurology, 2022, 24 : 441 - 452
  • [27] Treatment strategies for Leber hereditary optic neuropathy
    Jurkute, Neringa
    Harvey, Joshua
    Yu-Wai-Man, Patrick
    [J]. CURRENT OPINION IN NEUROLOGY, 2019, 32 (01) : 99 - 104
  • [28] Leber optic hereditary neuropathy plus dystonia
    Mahoui, S.
    Belkhamsa, O.
    Kaci, I. Ait
    Bendib, M. Abada
    Castelnovo, G.
    [J]. REVUE NEUROLOGIQUE, 2019, 175 (7-8) : 483 - 484
  • [29] Leber hereditary optic neuropathy and exercise intolerance
    Biolsi, B
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 : 116 - 117
  • [30] Developments in the Treatment of Leber Hereditary Optic Neuropathy
    Chen, Benson S.
    Yu-Wai-Man, Patrick
    Newman, Nancy J.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2022, 22 (12) : 881 - 892